Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Could bamboo be the superfood you’ve been missing? New study reveals shocking benefits
- Plastic is quietly making the world sicker — And it could double by 2040
- Global safety at risk? WHO slams US withdrawal
- From founding member to exit: Why the US decided to officially quit WHO
- What ADHD at age 10 could mean for your health at 46, warns study
-1763561110.jpg "Image of the day: November 19, 2025")
